Eli Lilly says next-gen obesity drug helps patients lose 28% of body weight
- Posted on May 21, 2026
- By Bing News
- 0 Views
- 1 min read
Eli Lilly says next-gen obesity drug helps patients lose 28% of body weight
NEW YORK, May 21 (Reuters) - Eli Lilly said on Thursday that its experimental drug retatrutide helped patients diagnosed with obesity lose more than 28% of their weight over a year and a half in a key trial that helps pave the way for the firm to seek regulatory approval and launch the drug next year. Shares of Lilly climbed 1% in premarket trading. The late-stage trial, which tracked weight
